-
New Study Looks At Obscure Cannabinoids For Treating Psoriasis, Eczema And Acne
Friday, August 25, 2023 - 3:23pm | 445A new study suggests that some lesser-known cannabinoids in hemp and marijuana can help with common skin conditions like psoriasis, eczema and acne. A study published by the journal 'Molecules' aptly notes, “Dermatological diseases pose a significant burden on the...
-
EXCLUSIVE: Hoth Reports Safety Data From Early-Stage Study Of BioLexa Platform In Eczema
Wednesday, September 8, 2021 - 7:56am | 285Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa platform. What Happened: New York-based Hoth says data from the Cohort 1 of a two-part, Phase 1b study of BioLexa...
-
Arcutis Stops ARQ-252 Vitiligo Trial After Formulation-Related Observations In Chronic Hand Eczema Study
Thursday, July 1, 2021 - 11:17am | 256Arcutis Biotherapeutics Inc (NASDAQ: ARQT) will terminate the Phase 2a trial evaluating ARQ-252 as a potential treatment for vitiligo. The study was initiated in March 2021. The decision is based on further analysis of the ARQ-252 drug formulation used in both this...
-
CBD And Eczema: What You Need To Know
Wednesday, June 17, 2020 - 12:54pm | 532By The Fresh Toast's Maria Loreto, provided exclusively to Benzinga Cannabis. Although there’s a lack of scientific research on CBD due to the compound’s strange legal standing, many experts are hopeful in the effect it could have on eczema. Eczema is a condition that targets a...
-
Meet One Woman Entrepreneur Who's Fighting For Diversity In The Cannabis Industry
Saturday, May 20, 2017 - 2:58pm | 890Bonita "Bo" Money was relatively well known as an actress and casting director. However, being a woman with an "ethnic" look, her career was filled with hurdles and challenges, even after her migration into the cannabis industry, which is usually received as a "progressive...
-
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
Monday, July 13, 2015 - 3:29pm | 529In a public conference call on Monday, Anacor Pharmaceuticals Inc (NASDAQ: ANAC) executives announced the results of two Phase 3 trials for a topical drug to treat atopic dermatitis, more commonly known as eczema. The treatment came in the form of a topical ointment, crisaborole. Atopic dermatitis...